혈전성 미세혈관병증의 병리 = Pathology of Thrombotic Microangiopathy

다국어 초록 (Multilingual Abstract)

Thrombotic microangiopathy (TMA) is a microvascular thrombotic lesion caused by endothelial injury and subsequent formation of platelet rich thrombus. TMA is first described as a classical pathologic feature of HUS/TTP. Renal biopsy finding of TMA represents kidney involvement of HUS/TTP as well as other diseases such as malignant hypertension, drug toxicity, eclampsia, pre-eclampsia, and several systemic infections. Autoimmune diseases and transplant kidney sometime also have TMA. It is needed to consider a complete autoimmune work-up of patients presenting with TMA including tests for ANA, ANCA, and ADAMTS13 inhibitory antibodies, because there are several reports of association with TMA in patients of SLE, anti-phospholipid syndrome, and ANCA-associated vasculitis.

참고문헌 (Reference)

1 Eremia V, "VEGF inhibition and renal thrombotic microangiopathy" 358 : 1129-1136, 2008

2 Zakarija A, "Ticlopidine and clopidogrel-associated thrombotic thrombocytopenic purpura(TTP); review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008)" 112 : S20-S24, 2009

3 Kwok SK, "Thrombotic thrombocytopenic purpura in systemic lupus erythema-tosus: risk factors and clinical outcome: a single center study" 18 : 16-21, 2009

4 Watanabe H, "Thrombotic thrombocytopenic purpura in a patient with rapidly progressive glomerulonephritis with both anti-glomerular basement membrane antibodies and myeloperoxidase anti-neutrophil cytoplasmic antibodies" 14 : 598-601, 2010

5 Benz K, "Thrombotic microangiopathy: new insights" 19 : 242-247, 2010

6 Ruggenenti P, "Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura" 60 : 831-846, 2001

7 Shibagaki Y, "Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/thrombotic thrombocytopenic purpura(TTP): can we differentiate one from the other?" 28 : 89-95, 2005

8 Noda S, "Thrombotic microangiopathy due to multiple autoantibodies related to antiphospholipid syndrome" 27 : 681-685, 2012

9 Fine DM, "Thrombotic microangiopathy and other glomerular disorders in the HIV-infected patient" 28 : 545-555, 2008

10 Symmers WSC, "Thrombotic microangiopathic hemolytic anemia(thrombotic microangiopathy)" 2 : 897-903, 1952

11 Nesher G, "Thrombotic microangiopathic hemolytic anemia in systemic lupus erythematosus" 24 : 165-172, 1994

12 Espinosa G, "Thrombotic microangiopathic hemolytic anemia and antiphospholipid antibodies" 63 : 730-736, 2004

13 Hamasaki K, "Systemic lupus erythematosus and thrombotic thrombocytopenic purpura: a case report and literature review" 22 : 355-358, 2003

14 Asamiya Y, "Successful treatment with Rituximab in a patient with TTP secondary to severe ANCA-associated vasculitis" 49 : 1589-1591, 2010

15 Remuzzi G, "Renal vascular and thrombotic effects of cyclosporine" 13 : 261-272, 1989

16 Baid S, "Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients" 10 : 146-153, 1999

17 Chansirikulchai S, "Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis" 4 : 345-353, 2009

18 Gurevich F, "Renal effects of angiogenesis therapy: update for the internist" 122 : 322-328, 2009

19 Gottschall JL, "Quinine induced immune thrombocytopeniaassociated with hemolytic uremic syndrome: A new clinical entity" 77 : 306-310, 1991

20 Cosio FG, "Prevalence of hepatitis C in patients with idiopathic glomerulopathies in native and transplant kidneys" 28 : 752-758, 1996

21 Kniaz D, "Postpartum hemolytic uremic syndrome associated with antiphospholipid antibodies: A case report and review of the literature" 12 : 126-133, 1992

22 Park YA, "Platelet count and prothrombin time help distinguish thrombotic thrmobocytopenic purpura-hemolytic uremic syndrome from disseminated intravascular coagulation in adults" 133 : 460-465, 2010

23 Lansigan F, "Microangiopathic haemolytic anaemia resembling thrombotic thrombocytopenic purpura in systemic lupus erythematosus: the role of ADAMTS13" 50 : 824-829, 2011

24 Habib R, "Maladie thrombotique arteriolecapillaire du rein chez l'enf ant" 3 : 891-894, 1958

25 Dragon-Durey M-A, "Heterozygous and homozygous factor H deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: Report and genetic analysis of 16 cases" 15 : 787-795, 2004

26 Matsuyama T, "Heterogeneous pathogenic processes of thrombotic microangiopathies in patients with connective tissue diseases" 102 : 371-378, 2009

27 Jenette JC, "Heptinstall's pathology of the kidney" Lippincott Williams & Wilkins 711-719, 2007

28 Gasser C, "Hamolytisch-uamische syndrome:Bilaterale Nierenrinden-nekrosen bei akuten erworbenen hamolytischen Anamien" 85 : 905-909, 1955

29 Gallay BJ, "Glomerulonephritis in renal allografts associated with hepatitis C infection: a possible relationship with transplant glomerulopathy in two cases" 26 : 662-667, 1995

30 Nachman PH, "Glomerular, vascular, and tubulointerstitial diseases" 7 : 185-189, 2008

31 McMinn JR, "Evaluation of women with clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome during pregnancy" 16 : 202-209, 2001

32 Satoskar AA, "De novo thrombotic microangiopapthy in renal allograft biopsies-role of antibody-mediated rejection" 10 : 1804-1811, 2010

33 Agrawal V, "Concomitant thrombotic thrombocytopenic purpura and ANCA-associated vasculitis in an adolescent" 26 : 1317-1320, 2011

34 Mannucci PM, "Changes in health and disease of the metalloproteinase that cleaves von Willebrand factor" 98 : 2730-2735, 2001

35 Murgo AJ, "Cancer and chemotherapy-associated thrmobotic microangiopathy, in Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura" 271 : 1992

36 Ashman N, "Belatacept as maintenance immunosuppression for postrenal transplant de novo drug-induced thrombocytic microangiopathy" 9 : 424-427, 2009

37 Furlan M, "Aetology and pathogenesis of throm-botic thrombocytopenic purpura and hemolytic uremic syndrome. The role of von Willebrand factor-cleaving protease" 14 : 437-454, 2001

38 Li PK, "Acute renal failure due to postpartum hemolytic uremic syndrome" 28 : 228-230, 1988

39 Nathanson S, "Acute neurological involvement in diar-rhea-associated hemolytic uremic syndrome" 5 : 1218-1228, 2010

40 Brunskill SJ, "A systematic review of randomized controlled trials for plasma exchange in the treatment of thrombotic thrombocytopenic purpura" 17 : 17-35, 2007